Immuneering Corporation (IMRX) has a market capitalization of $196.4M and trades at $5.41. The 52-week range is 1.1-10.08.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.3, Earnings Per Share (EPS) of $-1.27.
The stock has a beta of 0.43, operates in the Healthcare sector.
